Abstract
Background: Receptor tyrosine kinase (RTK) inhibitors as novel anticancer therapy are associated with clinical heart failure. Better understanding molecular mechanisms underlying such a side effect may provide new strategies to prevent RTK inhibitors-induced heart failure. Grb2-associated binder 1 (Gab1), a member of the docking protein family, is a central mediator for RTK signaling. We hypothesized that the deletion of Gab1 causes dilated cardiomyopathy and heart failure. Methods and Results: Using alpha-MHC-Cre mice and Gab1 loxp mice, we generated cardiac-specific Gab1 knockout (Gab1-cKO) mice. Gab1-cKO mice were viable and born at the expected Mendelian ratio. With echocardiography, hemodynamic measurements and histological analysis, we found that cardiac Gab1 deficiency in mice caused progressive dilated cardiomyopathy and heart failure. At age 3-6 months, ejection fraction and dp/dt max in Gab1-cKO mice were considerably lower than those in Gab1 wild-type littermates. Moreover, under mechanical stress via transverse aortic constriction at young age (around 6 weeks) before onset of heart failure, Gab1-cKO mice suffered more severe dilated cardiomyopathy and induced lethality. The deletion of Gab1 in heart during adulthood by crossing Gab1-loxp mice with tamaxifen-inducible alpha-MHC-Cre mice also resulted in cardiac dysfunction and heart failure. Mechanistically, we observed loss of mitochondrial membrane potential and increase of cardiomyocyte apoptosis in Gab1-cKO heart. Transmission electronic microscopy studies showed frequent damaged mitochondria with cristae lysis and apparent abnormal internal membrane whorls in Gab1-cKO heart. Signaling studies revealed that proapoptotic genes including p38 and caspase 3 were overly activated in Gab1-cKO heart. Gene array and quantitative PCR analysis showed that antiapoptotic genes such as Bcl2 were downregulated, whereas proapopotic genes such Bnip3 were upregulated in Gab1-cKO heart. Conclusion: Gab1 is a crucial regulator of cardiac function through maintaining mitochondrial integrity and cell survival, suggesting that the preservation of Gab1 signaling could be one of therapeutic strategies to prevent heart failure induced by anticancer RTK inhibitors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.